146 related articles for article (PubMed ID: 30151355)
1. T-Cell Leukemia/Lymphoma 1 (TCL1): An Oncogene Regulating Multiple Signaling Pathways.
Paduano F; Gaudio E; Mensah AA; Pinton S; Bertoni F; Trapasso F
Front Oncol; 2018; 8():317. PubMed ID: 30151355
[TBL] [Abstract][Full Text] [Related]
2. T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1.
Bresin A; Ragone G; Cristofoletti C; Arcelli D; Bassi C; Caprini E; Fiorenza MT; Helmer Citterich M; Russo G; Narducci MG
PLoS One; 2018; 13(10):e0204775. PubMed ID: 30286151
[TBL] [Abstract][Full Text] [Related]
3. Heat shock protein 70 regulates Tcl1 expression in leukemia and lymphomas.
Gaudio E; Paduano F; Ngankeu A; Lovat F; Fabbri M; Sun HL; Gasparini P; Efanov A; Peng Y; Zanesi N; Shuaib MA; Rassenti LZ; Kipps TJ; Li C; Aqeilan RI; Lesinski GB; Trapasso F; Croce CM
Blood; 2013 Jan; 121(2):351-9. PubMed ID: 23160471
[TBL] [Abstract][Full Text] [Related]
4. TCL1A expression delineates biological and clinical variability in B-cell lymphoma.
Aggarwal M; Villuendas R; Gomez G; Rodriguez-Pinilla SM; Sanchez-Beato M; Alvarez D; Martinez N; Rodriguez A; Castillo ME; Camacho FI; Montes-Moreno S; Garcia-Marco JA; Kimby E; Pisano DG; Piris MA
Mod Pathol; 2009 Feb; 22(2):206-15. PubMed ID: 18820675
[TBL] [Abstract][Full Text] [Related]
5. Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL.
Pekarsky Y; Palamarchuk A; Maximov V; Efanov A; Nazaryan N; Santanam U; Rassenti L; Kipps T; Croce CM
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19643-8. PubMed ID: 19064921
[TBL] [Abstract][Full Text] [Related]
6. Tcl1 protein functions as an inhibitor of de novo DNA methylation in B-cell chronic lymphocytic leukemia (CLL).
Palamarchuk A; Yan PS; Zanesi N; Wang L; Rodrigues B; Murphy M; Balatti V; Bottoni A; Nazaryan N; Alder H; Rassenti L; Kipps TJ; Freitas M; Croce CM; Pekarsky Y
Proc Natl Acad Sci U S A; 2012 Feb; 109(7):2555-60. PubMed ID: 22308499
[TBL] [Abstract][Full Text] [Related]
7. AKT-pathway inhibition in chronic lymphocytic leukemia reveals response relationships defined by TCL1.
Schrader A; Popal W; Lilienthal N; Crispatzu G; Mayer P; Jones D; Hallek M; Herling M
Curr Cancer Drug Targets; 2014; 14(8):700-12. PubMed ID: 25348018
[TBL] [Abstract][Full Text] [Related]
8. TCL1A and ATM are co-expressed in chronic lymphocytic leukemia cells without deletion of 11q.
Garding A; Bhattacharya N; Haebe S; Müller F; Weichenhan D; Idler I; Ickstadt K; Stilgenbauer S; Mertens D
Haematologica; 2013 Feb; 98(2):269-73. PubMed ID: 22875623
[TBL] [Abstract][Full Text] [Related]
9. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression.
Bichi R; Shinton SA; Martin ES; Koval A; Calin GA; Cesari R; Russo G; Hardy RR; Croce CM
Proc Natl Acad Sci U S A; 2002 May; 99(10):6955-60. PubMed ID: 12011454
[TBL] [Abstract][Full Text] [Related]
10. Par-4 overexpression impedes leukemogenesis in the Eµ-TCL1 leukemia model through downregulation of NF-κB signaling.
Greene JT; Mani R; Ramaswamy R; Frissora F; Yano M; Zapolnik K; Harrington B; Wasmuth R; Tran M; Mo X; McKenna M; Rangnekar VM; Byrd JC; Bondada S; Muthusamy N
Blood Adv; 2019 Apr; 3(8):1255-1266. PubMed ID: 30987970
[TBL] [Abstract][Full Text] [Related]
11. Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Emu-TCL1 transgenic mice.
Zanesi N; Aqeilan R; Drusco A; Kaou M; Sevignani C; Costinean S; Bortesi L; La Rocca G; Koldovsky P; Volinia S; Mancini R; Calin G; Scott CP; Pekarsky Y; Croce CM
Cancer Res; 2006 Jan; 66(2):915-20. PubMed ID: 16424025
[TBL] [Abstract][Full Text] [Related]
12. The Modes of Dysregulation of the Proto-Oncogene T-Cell Leukemia/Lymphoma 1A.
Stachelscheid J; Jiang Q; Herling M
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771618
[TBL] [Abstract][Full Text] [Related]
13. The proto-oncogene TCL1A deregulates cell cycle and genomic stability in CLL.
Stachelscheid J; Jiang Q; Aszyk C; Warner K; Bley N; Müller T; Vydzhak O; Symeonidis K; Crispatzu G; Mayer P; Blakemore SJ; Goehring G; Newrzela S; Hippler S; Robrecht S; Kreuzer KA; Pallasch C; Krüger M; Lechner A; Fischer K; Stilgenbauer S; Beutner D; Hallek M; Auguin D; Hüttelmaier S; Bloehdorn J; Vasyutina E; Herling M
Blood; 2023 Mar; 141(12):1425-1441. PubMed ID: 36179280
[TBL] [Abstract][Full Text] [Related]
14. Nutlin-3 downregulates the expression of the oncogene TCL1 in primary B chronic lymphocytic leukemic cells.
Voltan R; di Iasio MG; Bosco R; Valeri N; Pekarski Y; Tiribelli M; Secchiero P; Zauli G
Clin Cancer Res; 2011 Sep; 17(17):5649-55. PubMed ID: 21753157
[TBL] [Abstract][Full Text] [Related]
15. TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia.
Bresin A; D'Abundo L; Narducci MG; Fiorenza MT; Croce CM; Negrini M; Russo G
Cell Death Dis; 2016 Jan; 7(1):e2071. PubMed ID: 26821067
[TBL] [Abstract][Full Text] [Related]
16. T-cell leukemia 1 expression in nodal Epstein-Barr virus-negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma.
Gualco G; Weiss LM; Barber GN; Bacchi CE
Hum Pathol; 2010 Sep; 41(9):1238-44. PubMed ID: 20382409
[TBL] [Abstract][Full Text] [Related]
17. TCL1 expression patterns in Waldenström macroglobulinemia.
Lemal R; Bard-Sorel S; Montrieul L; Bay JO; Ravinet A; Ledoux-Pilon A; Cagnard N; Bailly S; Morel P; Charlotte F; Leleu X; Poulain S; Déchelotte PJ; Hermine O; Leblond V; Tournilhac O; Guièze R
Mod Pathol; 2016 Jan; 29(1):83-8. PubMed ID: 26493619
[TBL] [Abstract][Full Text] [Related]
18. TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemia.
Balatti V; Rizzotto L; Miller C; Palamarchuk A; Fadda P; Pandolfo R; Rassenti LZ; Hertlein E; Ruppert AS; Lozanski A; Lozanski G; Kipps TJ; Byrd JC; Croce CM; Pekarsky Y
Proc Natl Acad Sci U S A; 2015 Feb; 112(7):2169-74. PubMed ID: 25646413
[TBL] [Abstract][Full Text] [Related]
19. Expression of the TCL1 gene at 14q32 in B-cell malignancies but not in adult T-cell leukemia.
Takizawa J; Suzuki R; Kuroda H; Utsunomiya A; Kagami Y; Joh T; Aizawa Y; Ueda R; Seto M
Jpn J Cancer Res; 1998 Jul; 89(7):712-8. PubMed ID: 9738977
[TBL] [Abstract][Full Text] [Related]
20. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.
Pekarsky Y; Santanam U; Cimmino A; Palamarchuk A; Efanov A; Maximov V; Volinia S; Alder H; Liu CG; Rassenti L; Calin GA; Hagan JP; Kipps T; Croce CM
Cancer Res; 2006 Dec; 66(24):11590-3. PubMed ID: 17178851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]